- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07949292
Home Visits and Telephone-Supported Education for Adults With Type 2 Diabetes
Effects of Home Visits and Telephone-Supported Educational Interventions on Diabetes Knowledge, Self-Care Behaviors, and Diabetes-Related Difficulties in Individuals With Type 2 Diabetes Attending a Family Health Center
This study aims to evaluate the effects of home visits and telephone-supported education on diabetes knowledge, self-care behaviors, and diabetes-related difficulties in adults with type 2 diabetes attending a family health center in Türkiye. The study will examine whether these educational approaches help participants better understand their diabetes, manage daily self-care, and cope with difficulties related to living with diabetes.
Aperçu de l'étude
Statut
Les conditions
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
Istanbul
-
Istanbul, Istanbul, Turquie (Türkiye), 34035
- Recrutement
- Şehit İbrahim Ceylan Aile Sağlığı Merkezi
-
Contact:
- Rabia Orhanoğlu
- Numéro de téléphone: +90 545 737 63 54
- E-mail: rabiaorhanoglu@gmail.com
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
Aged 18-65 years. Diagnosed with type 2 diabetes mellitus for at least 6 months. Able to read and understand Turkish. No health condition that impairs cognition or communication. Owns a smartphone. Uses insulin, oral antidiabetic medication, or both. Willing to participate in the study.
Exclusion Criteria:
Pregnancy. Inability to complete the data collection instruments due to a cognitive or psychiatric condition.
Unwillingness to participate in the study.
-
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Soins de soutien
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Home Visit-Based Education
Participants in this group will receive nurse-led diabetes education through home visits. The education will focus on diabetes knowledge, daily self-care behaviors, and coping with diabetes-related difficulties. |
A nurse will provide four structured, face-to-face diabetes education sessions in participants' homes, once weekly for four weeks. Each visit will last approximately 45-60 minutes and use PowerPoint presentations, informational brochures, direct instruction, and questions and answers. Weekly topics will cover: (1) diabetes, symptoms, risk factors, complications, hypoglycemia, hyperglycemia, and regular health checks; (2) nutrition, carbohydrate management, food label reading, portion control, and physical activity; (3) medication adherence, insulin use, blood glucose monitoring, foot care, oral care, sleep, and screening; and (4) diabetes-related difficulties, stress management, problem-solving, social support, personal strengths, goal setting, and behavior change. |
|
Expérimental: Telephone-Supported Education
Participants in this group will receive nurse-led, telephone-supported diabetes education. The education will focus on diabetes knowledge, daily self-care behaviors, and coping with diabetes-related difficulties. |
A nurse will provide four structured tele-nursing sessions over one month, once weekly, using telephone calls, video calls, and digital educational materials, including PowerPoint presentations and brochures. Each session will last approximately 15-25 minutes, with additional counseling time when needed. The educational content will be similar to that provided to the home visit group. Weekly topics will cover: (1) diabetes, symptoms, risk factors, complications, hypoglycemia, hyperglycemia, and regular health checks; (2) nutrition, carbohydrate management, food label reading, portion control, and physical activity; (3) medication adherence, insulin use, blood glucose monitoring, foot care, oral care, sleep, and screening; and (4) diabetes-related difficulties, stress management, problem-solving, social support, personal strengths, goal setting, and behavior change. Sessions will reinforce learning, support motivation, and address individual self-care needs. |
|
Aucune intervention: Usual Care Control Group
Participants in this group will continue to receive usual care at the family health center. They will not receive the study-specific home visit-based or telephone-supported educational interventions during the study period. |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change in Diabetes Health-Promoting Self-Care Behaviors
Délai: Baseline (before education), immediately after the 4-week education period, and 1 month after completion of education.
|
Changes in self-care behaviors will be assessed using the Turkish version of the Diabetes Health-Promoting Self-Care Scale. The scale includes 27 items across seven domains: interpersonal relationships, personal health responsibility, diet, exercise, foot care, blood glucose self-monitoring, and adherence to the recommended regimen. Each item is scored from 1 to 5, giving a total score of 27-135. Higher scores indicate better health-promoting self-care behaviors. |
Baseline (before education), immediately after the 4-week education period, and 1 month after completion of education.
|
|
Change in Diabetes Knowledge
Délai: Baseline (before education), immediately after the 4-week education period, and 1 month after completion of education.
|
Changes in diabetes knowledge will be assessed using the 28-item Adult Diabetes Knowledge Scale developed by Yavuz and Erol. Each correct answer receives 1 point; incorrect and "I do not know" responses receive 0 points. Total scores range from 0 to 28, with higher scores indicating greater diabetes knowledge. |
Baseline (before education), immediately after the 4-week education period, and 1 month after completion of education.
|
|
Change in Diabetes-Related Difficulties
Délai: Baseline (before education), immediately after the 4-week education period, and 1 month after completion of education.
|
Changes in diabetes-related difficulties will be assessed using the 30-item Type 2 Diabetes Strengths and Difficulties Scale developed by Bilgehan and Inkaya. The scale assesses difficulties related to lack of knowledge, individual difficulties, and psychosocial difficulties. Each item is scored from 1 (never experience difficulty) to 5 (always experience difficulty), giving a total score of 30-150. Higher scores indicate greater diabetes-related difficulties. |
Baseline (before education), immediately after the 4-week education period, and 1 month after completion of education.
|
Collaborateurs et enquêteurs
Parrainer
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- 26-19
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
There is currently no plan to share individual participant data with other researchers.
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .